(5ALPHA,6BETA)-17-(CYCLOPROPYLMETHYL)-4,5-EPOXY-MORPHINAN-3,6,14-TRIOL HYDRATE
(5ALPHA,6BETA)-17-(CYCLOPROPYLMETHYL)-4,5-EPOXY-MORPHINAN-3,6,14-TRIOL HYDRATE Basic information
- Product Name:
- (5ALPHA,6BETA)-17-(CYCLOPROPYLMETHYL)-4,5-EPOXY-MORPHINAN-3,6,14-TRIOL HYDRATE
- Synonyms:
-
- 6BETA-NALTREXOL HYDRATE
- (5ALPHA,6BETA)-17-(CYCLOPROPYLMETHYL)-4,5-EPOXY-MORPHINAN-3,6,14-TRIOL HYDRATE
- (5α,6β)-17-(Cyclopropylmethyl)-4,5-epoxy-morphinan-3,6,14-triol hydrate
- 6β-Naltrexol hydrate
- MF:
- C20H27NO5
- MW:
- 361.43
- Mol File:
- Mol File
More
Less
(5ALPHA,6BETA)-17-(CYCLOPROPYLMETHYL)-4,5-EPOXY-MORPHINAN-3,6,14-TRIOL HYDRATE Chemical Properties
- storage temp.
- 2-8°C
- solubility
- DMSO: ~12 mg/mL
- form
- powder
- color
- white
MSDS
- Language:English Provider:SigmaAldrich
More
Less
(5ALPHA,6BETA)-17-(CYCLOPROPYLMETHYL)-4,5-EPOXY-MORPHINAN-3,6,14-TRIOL HYDRATE Usage And Synthesis
Biochem/physiol Actions
Neutral antagonist of the μ-opioid receptor. A reduction of withdrawal effects associated with neutral μ-opioid receptor antagonists may offer advantages in treating opioid overdose and addiction.